James L. Zazzali

Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy

Allen P. Kaplan, Dennis K. Ledford, Mark Ashby et al. · Journal of Allergy and Clinical Immunology · 2013 · 552 citations

Symptomatic Chronic, Allergy Medicine, Clinical Dermatology +5

Timing and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticaria

Allen P. Kaplan, Marta Ferrer, Jonathan A. Bernstein et al. · Journal of Allergy and Clinical Immunology · 2015 · 193 citations · Full text

Implementing Evidence-Based Medicine

Stephen M. Shortell, James L. Zazzali, Lawton R. Burns et al. · Medical Care · 2001 · 153 citations

Evaluating the minimally important difference of the urticaria activity score and other measures of disease activity in patients with chronic idiopathic urticaria

Susan D. Mathias, Ross D. Crosby, James L. Zazzali et al. · Annals of Allergy Asthma & Immunology · 2011 · 117 citations

Rheumatology, Urticaria Activity Score, Physical Activity +8

Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab

J.S. Wefel, Timothy F. Cloughesy, James L. Zazzali et al. · Neuro-Oncology · 2011 · 104 citations · Full text